Biodol Therapeutics
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
165 Rue Denis Papin, Montarnaud, Occitan...Website
www.biodol.euRevenue
<$5 MillionIndustry
About Biodol Therapeutics
Is Biodol Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Biodol Therapeutics
Check out if Biodol Therapeutics is spiking on competitors!
Click to see if Biodol Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Biodol Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Biodol Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Biodol Therapeutics launches new products
Funding: Get notified immidiatlly once Biodol Therapeutics has new funding data
Biodol Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Biodol Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
Biodol Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biodol Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biodol Therapeutics.
Biodol Therapeutics Tech Stack
A closer look at the technologies used by Biodol Therapeutics
Top Business Services Companies
Frequently Asked Questions Regarding Biodol Therapeutics
Biodol Therapeutics is a biotechnology company founded in 2015 that specializes in developing first-in-class compounds for the treatment of chronic pain, particularly neuropathic pain. The company has identified the FLT3 receptor as a key target in pain management and has developed proprietary inhibitors that enhance opioid efficacy while reducing... Read More